Original Research and the Latest News
Recent Posts
Using NLP Data to Classify Patient Segments in Clinical Trial Data
One of the most common and powerful approaches in NLP provides the content experts an opportunity to label each data segment for...
When Good Things DON’T Come to Those Who Wait: How Pharma Companies Compare in Governance Efficiency
Predicting when a competing product will be approved is essential in any commercial forecast and for any business insights team...
What do the big players have in store for the Diabetes market in the next 12 months?
Diabetes is one of the most prevalent diseases in the U.S., afflicting over 29 million people across Type 1 and Type 2 patients,...
Pharma Forecasting Case Study – Valuing the Impact of Development Delays
A multinational pharmaceutical firm asked Ozmosi to provide forecasts to assess the market impact of delays in delivering new...
Case Study Portfolio – Prioritization aligning teams on value and risk and guiding investment
The Asia-Pacific R&D unit of a large, multinational pharmaceutical company needed a pipeline prioritization approach to...
Covid-19 Clinical Trials and Where to Get Treated Update
Here is a quick update on the ever-evolving world of COVID-19 trials. Since our initial posting on this topic three weeks ago,...
Pharma Forecasting Case Study – Shaping R&D Strategy
The oncology team of a major multinational pharmaceutical company asked Ozmosi to provide additional forecasting support for a...
Covid-19 Clinical Trials and Where to Get Treated
We all know the basics for fighting the COVID-19 virus, like washing our hands and staying socially distant from one another,...
ELI LILLY in the Diabetes Market
For years, Eli Lilly’s main contributions to the Diabetes market were their insulins: fast-acting analog Humalog® and human...
Case Study Market Scan – Understanding the Competition and Defining Opportunity
A small startup medical device company needed a broader understanding of its potential competitors and a more complete picture...
PHARMA FORECASTING CASE STUDY – Estimating the Prevalence of Orphan Diseases
When in-house experts’ forecasts for the market potential of a treatment for an orphan disease conflicted, the management team...
Forecasting – Applying Pharmaceutical Valuation Approach in the Foster Care Setting
The Children’s Hospital of Philadelphia–Policy Lab approached Ozmosi for help in supporting its application for federal funding...
Case Study Market Scan – Surveying Pharmaceutical Markets in Asia Pacific
A regional marketing team for a multinational pharmaceutical company needed a complete market overview of a neuroscience therapy...
Building a Case Study Portfolio Framework
When a pharmaceutical company in China realized it needed outside help to identify and close the gaps in its R&D portfolio,...
A Gift for Patients – Medicare to Cover Lung Cancer Screening
LUNG CANCER SCREENING UPDATE: As of February 5, 2015, effective immediately, Medicare will cover lung cancer screening by...
We’re Back!
Ozmosi has been on a purpose-driven hiatus peppered with innovation, development and growth. In less than one year, we have...
7 Small-Cap Biotech Companies to Watch at AACR in April
We anticipate scientific reviews and clinical trial updates from 40 companies on nearly 80 oncology development programs at the...
Tango Therapeutics: Early Stage Oncology Pipeline Comes Into Focus in April
The Annual Meeting of the American Association for Cancer Research (AACR) is taking place April 5-10 in San Diego. AACR...
Recent Tweets
Get Started with OZMOSI
We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.
600 Warren Ave,
Spring Lake, NJ 07762